<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type='text/xsl' href='../../ld2webpage.xsl'?>
<LOBBYINGDISCLOSURE2>
  <imported>N</imported>
  <pages>18</pages>
  <submitURL>
  </submitURL>
  <organizationName>Biotechnology Innovation Organization</organizationName>
  <prefix>
  </prefix>
  <firstName>
  </firstName>
  <lastName>
  </lastName>
  <registrantDifferentAddress>N</registrantDifferentAddress>
  <address1>1201 Maryland Avenue SW</address1>
  <address2>Suite 900</address2>
  <city>Washington</city>
  <state>DC</state>
  <zip>20024</zip>
  <zipext>
  </zipext>
  <country>USA</country>
  <principal_city>
  </principal_city>
  <principal_state>
  </principal_state>
  <principal_zip>
  </principal_zip>
  <principal_zipext>
  </principal_zipext>
  <principal_country>
  </principal_country>
  <contactIntlPhone>
  </contactIntlPhone>
  <selfSelect>Y</selfSelect>
  <clientName>Biotechnology Innovation Organization</clientName>
  <clientGovtEntity>N</clientGovtEntity>
  <senateID>6245-12</senateID>
  <houseID>325050000</houseID>
  <reportYear>2016</reportYear>
  <reportType>Q1</reportType>
  <terminationDate>
  </terminationDate>
  <noLobbying>
  </noLobbying>
  <income>
  </income>
  <expenses>2260000.00</expenses>
  <expensesMethod>A</expensesMethod>
  <printedName>Tom DiLenge</printedName>
  <signedDate>4/20/2016 9:59:24 PM</signedDate>
  <alis>
    <ali_info>
      <issueAreaCode>AGR</issueAreaCode>
      <specific_issues>
        <description>EPA Regulations on Biotechnology
--Reauthorization of Pesticide Registration Improvement Act (PRIA) 
--EPA Points to Consider Guidance Document for GE Algae
Review of the Federal Coordinated Framework for Biotechnology Products
USDA/APHIS Agricultural Biotechnology Regulations
--Efficient Science-Based Review of Biotech Products
--USDA Decision on GE Crops Environmental Impact Statement
--Co-existence of Production Systems
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Foreign Agricultural Biotechnology Laws and Regulations
--EU Ag-Biotech Policies and Regulations
--China Biotechnology Regulations
--Asynchrony of International Approvals
--Like-minded Countries Initiatives
--Korea Biotechnology Regulations
Review and Labeling of Food Derived From Biotechnology
--H.R. 1599: Safe and Accurate Food Labeling Act of 2015
--U.S. Government Policy
--S.2609: The Biotech Labeling Solutions Act
Adventitious Presence (Low Level Presence)
--International Low Level Presence Policies
Funding for the USDA
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Genetically Engineered (GE) Animals
--Amendment on GE Salmon Labeling
--Amendment to Restrict FDA Approval of GE Salmon
--Labeling
--One Health Legislation (Senate Discussion Draft)
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
--FDA Approval
Funding for Biomass Crop Assistance Program
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
TransAtlantic Trade and Investment Partnership
--Ag-Biotech Issues 
    </description>
      </specific_issues>
      <federal_agencies>Environmental Protection Agency (EPA), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Office of Science &amp; Technology Policy (OSTP), U.S. Trade Representative (USTR)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Dana </lobbyistFirstName>
          <lobbyistLastName>OBrien</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Brian </lobbyistFirstName>
          <lobbyistLastName>Baenig (House and Senate Only)</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tracey </lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Matthew </lobbyistFirstName>
          <lobbyistLastName>OMara</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>ANI</issueAreaCode>
      <specific_issues>
        <description>Genetically Engineered (GE) Animals
--Amendment on GE Salmon Labeling
--Amendment to Restrict FDA Approval of GE Salmon
--Labeling
--One Health Legislation (Senate Discussion Draft)
--FDA Approval
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017


</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Brian </lobbyistFirstName>
          <lobbyistLastName>Baenig (House and Senate Only)</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Dana </lobbyistFirstName>
          <lobbyistLastName>OBrien</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tracey </lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne </lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>BUD</issueAreaCode>
      <specific_issues>
        <description>Funding for the USDA
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Funding for Biomass Crop Assistance Program
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Funding for FDA
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Funding for Centers for Disease Control and Prevention Vaccine Programs
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 

Funding for National Institutes of Health
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Funding for Biofuels
--Department of Defense Funding of Advanced Biofuels
--Energy and Water Development and Related Agencies Appropriations Act for FY 2017
Funding for Renewable Chemicals/Bio-based Products
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Energy Basic Research Funding
--Advanced Research Projects Agency 
--DOE Office of Science
--Energy and Water Development and Related Agencies Appropriations Act for FY 2017
</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Brian </lobbyistFirstName>
          <lobbyistLastName>Baenig (House and Senate Only)</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tracey </lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Kathleen </lobbyistFirstName>
          <lobbyistLastName>Holcombe</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Amy </lobbyistFirstName>
          <lobbyistLastName>Walker</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Kelly </lobbyistFirstName>
          <lobbyistLastName>Cappio</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Phyllis </lobbyistFirstName>
          <lobbyistLastName>Arthur</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Nicolas</lobbyistFirstName>
          <lobbyistLastName>Magallanes</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>CHM</issueAreaCode>
      <specific_issues>
        <description>Funding for Renewable Chemicals/Bio-based Products
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Renewable Chemicals/Bio-based Products (Non-Funding)
--Nomenclature Usage
--S. 2271: The Renewable Chemicals Act
--S. 1656/H.R. 2883: Master Limited Partnership Parity Act
--H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act
--H.R. 2576: TSCA Modernization Act 
--S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act 
--Implementation of the Agricultural Act of 2014
--Reauthorization of USDA Bio-Preferred Program
--Investment Tax Credit for Renewable Chemicals and Bio-based Products
EPA Regulations on Biotechnology
--Reauthorization of Pesticide Registration Improvement Act (PRIA) 
 
       </description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Tracey </lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Rina Singh</lobbyistFirstName>
          <lobbyistLastName>Singh</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne </lobbyistFirstName>
          <lobbyistLastName>Haggerty </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Dana</lobbyistFirstName>
          <lobbyistLastName>O'Brien</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Charles</lobbyistFirstName>
          <lobbyistLastName>Fritts</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>CSP</issueAreaCode>
      <specific_issues>
        <description>Genetically Engineered (GE) Animals
--Amendment on GE Salmon Labeling
--Amendment to Restrict FDA Approval of GE Salmon
--Labeling
--One Health Legislation (Senate Discussion Draft)
--FDA Approval
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Review and Labeling of Food Derived From Biotechnology
--H.R. 1599: Safe and Accurate Food Labeling Act of 2015
--S.2609: The Biotech Labeling Solutions Act
--U.S. Government Policy
USDA/APHIS Agricultural Biotechnology Regulations
--Efficient Science-Based Review of Biotech Products
--USDA Decision on GE Crops Environmental Impact Statement
--Co-existence of Production Systems
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Biosimilars
--Implementation of Affordable Care Act
--Interchangeability and Pharmacy Substitution
--Naming
--Brazil Biologics Regulations
Drug Importation
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Food &amp; Drug Administration (FDA), Commerce - Dept of (DOC)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Brian </lobbyistFirstName>
          <lobbyistLastName>Baenig (House and Senate Only)</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tracey </lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Dana </lobbyistFirstName>
          <lobbyistLastName>OBrien</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Nicolas</lobbyistFirstName>
          <lobbyistLastName>Magallanes</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Deborah </lobbyistFirstName>
          <lobbyistLastName>Shelton</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Scott </lobbyistFirstName>
          <lobbyistLastName>McGoohan</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Kathleen</lobbyistFirstName>
          <lobbyistLastName>Holcombe</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>CPT</issueAreaCode>
      <specific_issues>
        <description>TransPacific Partnership
--Data and Intellectual Property Protection for Pharmaceuticals
Patent Reform
--H.R. 9: Innovation Act
--S.1137: The PATENTS Act of 2015
Bayh-Dole Act/Tech Transfer
--Commercialization of Federally Funded Research Initiative
--March-In Rights
Intellectual Property International Enforcement
Pacific Alliance IP Harmonization
Inter Partes Review
--Implementation of the American Invents Act of 2011
--S. 1137: The PATENTS Act of 2015 
World Trade Organization - Special 301 Submissions
--Middle East Issues
--Latin American Issues
--Canada Issues
UN Commission on Access to Medicines </description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), Natl Institutes of Health (NIH), Commerce - Dept of (DOC), Patent &amp; Trademark Office (PTO)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Jamie </lobbyistFirstName>
          <lobbyistLastName>Gregorian</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Charles </lobbyistFirstName>
          <lobbyistLastName>Fritts</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Hans </lobbyistFirstName>
          <lobbyistLastName>Sauer</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Cartier</lobbyistFirstName>
          <lobbyistLastName>Esham</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne </lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom </lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Joseph</lobbyistFirstName>
          <lobbyistLastName>Damond</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>ENG</issueAreaCode>
      <specific_issues>
        <description>Funding for Renewable Chemicals/Bio-based Products
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
EPA Regulation of Biotechnology
--EPA Points to Consider Guidance Document for GE Algae
Energy Basic Research Funding
--Advanced Research Projects Agency 
--DOE Office of Science
--Energy and Water Development and Related Agencies Appropriations Act for FY 2017
Funding for Biofuels   
--Department of Defense Funding of Advanced Biofuels
--Energy and Water Development and Related Agencies Appropriations Act for FY 2017
Renewable Fuel Standard
--The 2014-2016 Final Rule
--Departments of Interior, and Related Agencies Appropriations Act for FY 2017
Review of the Federal Coordinated Framework for Biotechnology Products
Renewable Chemicals/Bio-based Products (Non-Funding)
--Implementation of the Agricultural Act of 2014
--Investment Tax Credit for Renewable Chemicals and Bio-based Products
--Nomenclature Usage
--Reauthorization of USDA Bio-Preferred Program
--S. 2271: The Renewable Chemicals Act
--S. 1656/H.R. 2883: Master Limited Partnership Parity Act
--H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act
--H.R. 2576: TSCA Modernization Act 
--S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act 
Biofuels (Non-Funding)
--Production Tax Credit Extension
--S. 1239/H.R. 1736: to amend the Clean Air Act with respect to the ethanol waiver for the Reid vapor pressure limitations under that Act
--S. 2658: Federal Aviation Administration Reauthorization Act of 2016
----Franken-Grassley Amendment 
Funding for Biomass Crop Assistance Program
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA), Agriculture - Dept of (USDA), Office of Science &amp; Technology Policy (OSTP)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Tracey</lobbyistFirstName>
          <lobbyistLastName> LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Brian </lobbyistFirstName>
          <lobbyistLastName>Baenig (House and Senate Only)</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Dana </lobbyistFirstName>
          <lobbyistLastName>OBrien</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Rina </lobbyistFirstName>
          <lobbyistLastName>Singh</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Charles </lobbyistFirstName>
          <lobbyistLastName>Fritts</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Erick</lobbyistFirstName>
          <lobbyistLastName>Lutt</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>FOO</issueAreaCode>
      <specific_issues>
        <description>Genetically Engineered (GE) Animals
--Amendment on GE Salmon Labeling
--Amendment to Restrict FDA Approval of GE Salmon
--Labeling
--One Health Legislation (Senate Discussion Draft)
--FDA Approval
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Review and Labeling of Food Derived From Biotechnology
--H.R. 1599: Safe and Accurate Food Labeling Act of 2015
--U.S. Government Policy
--S.2609: The Biotech Labeling Solutions Act

</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Brian </lobbyistFirstName>
          <lobbyistLastName>Baenig (House and Senate Only)</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Dana </lobbyistFirstName>
          <lobbyistLastName>OBrien</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tracey</lobbyistFirstName>
          <lobbyistLastName> LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>FUE</issueAreaCode>
      <specific_issues>
        <description>Funding for Renewable Chemicals/Bio-based Products
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
EPA Regulation of Biotechnology
--EPA Points to Consider Guidance Document for GE Algae
Energy Basic Research Funding
--Advanced Research Projects Agency 
--DOE Office of Science
--Energy and Water Development and Related Agencies Appropriations Act for FY 2017
Funding for Biofuels   
--Department of Defense Funding of Advanced Biofuels
--Energy and Water Development and Related Agencies Appropriations Act for FY 2017
Renewable Fuel Standard
--The 2014-2016 Final Rule
--Departments of Interior, and Related Agencies Appropriations Act for FY 2017
Review of the Federal Coordinated Framework for Biotechnology Products
Renewable Chemicals/Bio-based Products (Non-Funding)
--Implementation of the Agricultural Act of 2014
--Investment Tax Credit for Renewable Chemicals and Bio-based Products
--Nomenclature Usage
--Reauthorization of USDA Bio-Preferred Program
--S. 2271: The Renewable Chemicals Act
--S. 1656/H.R. 2883: Master Limited Partnership Parity Act
--H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act
--H.R. 2576: TSCA Modernization Act 
--S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act 
Biofuels (Non-Funding)
--Production Tax Credit Extension
--S. 1239/H.R. 1736: to amend the Clean Air Act with respect to the ethanol waiver for the Reid vapor pressure limitations under that Act
--S. 2658: Federal Aviation Administration Reauthorization Act of 2016
----Franken-Grassley Amendment 
Funding for Biomass Crop Assistance Program
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), Office of Science &amp; Technology Policy (OSTP)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Tracey </lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Erick </lobbyistFirstName>
          <lobbyistLastName>Lutt</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Dana </lobbyistFirstName>
          <lobbyistLastName>OBrien</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Rina </lobbyistFirstName>
          <lobbyistLastName>Singh</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Charles</lobbyistFirstName>
          <lobbyistLastName> Fritts</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Brian </lobbyistFirstName>
          <lobbyistLastName>Baenig (House and Senate Only)</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>HCR</issueAreaCode>
      <specific_issues>
        <description>Biosimilars
--Coding
--Implementation of Affordable Care Act
--Interchangeability and Pharmacy Substitution
--Naming
--Patent Certification
--Brazil Biologics Regulations
Funding for National Institutes of Health
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Funding for Centers for Disease Control and Prevention Vaccine Programs
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
340B Drug Pricing Program
--Implementation of Affordable Care Act
--Program Implementation &amp; Oversight
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Medicaid Pricing and Rebates
--Average Manufacturer Price Calculations
--Implementation of Affordable Care Act
Drug Importation
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Diagnostics and Personalized Medicine Regulation and Oversight
Funding for FDA
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Biodefense Research, Development and Procurement Issues (Nonfunding)
Reimbursement for Innovative Products
--Medicare Part B Physician-Administered Products
--Medicare Part D Prescription Drug Program: 
----CMS Proposed Rule on Protected Classes
--Value-based Contracting and Communications
Drug Evaluation and Review
--Compassionate Use/Expanded Access
--FDA Proposed Rule on Changes to Drug Labeling
--Implementation of the FDA Safety and Innovation Act
--Reauthorization of the Prescription Drug User Fee Act
--Special Medical Use/Limited Population Drug
---- ADAPT Act (House Discussion Draft)
Senate Innovation for Healthier Americans
--Biomarkers and Regulatory Science Improvements
--Expanded Access to Investigational Drugs
--Expedited Pathways
--FDA Hiring Flexibility
--FDA Management and Financial Accountability
--Innovation Incentives
--Longitudinal Study of Chronic Diseases
--Patient Access to Approved Drugs
--Patient-Focused Drug Development
--Use of Real-World Evidence
--Vaccine and Anti-Microbial Resistance Product Development and Incentives
----S. 195: PATH Act 
--Communication with Healthcare Professionals and Payors
--Priority Review Voucher Programs
Priority Review of Generic Drugs
----S. 2615: Increasing Competition in Pharmaceuticals Act 
Vaccines and Infectious Diseases - General
Government Price Reporting
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Gene Editing Technologies
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Precision Medicine Initiative
Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 

Antibiotic &amp; Diagnostic Tax Credit
--H.R. 3539: Antibiotic &amp; Diagnostic Innovation Act
Drug Manufacturing, Quality &amp; Distribution
--Supply Chain Integrity and Traceability
Affordable Care Act Implementation
--Third Party Support of Patient Premiums and Cost-Sharing Obligations
Combating Antibiotic-Resistant Bacteria (CARB) Initiative
Vaccine Access/Financing
--Adult Immunization (Senate Discussion Draft)
--Implementation of Affordable Care Act
--Senate Chronic Care Working Group Proposals
--Vaccine Injury Compensation Program 
TransPacific Partnership
--Data and Intellectual Property Protection for Pharmaceuticals
--Reimbursement Transparency 
Orphan Drug Act Tax Credit
UN Commission on Access to Medicines </description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Food &amp; Drug Administration (FDA), U.S. HOUSE OF REPRESENTATIVES, Commerce - Dept of (DOC), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), U.S. Trade Representative (USTR), Health &amp; Human Services - Dept of (HHS)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Laurel </lobbyistFirstName>
          <lobbyistLastName>Todd</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Joseph</lobbyistFirstName>
          <lobbyistLastName>Damond</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Catharine</lobbyistFirstName>
          <lobbyistLastName>Harris</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Deborah </lobbyistFirstName>
          <lobbyistLastName>Shelton</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Scott </lobbyistFirstName>
          <lobbyistLastName>McGoohan</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Nicolas</lobbyistFirstName>
          <lobbyistLastName>Magallanes</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Kathleen </lobbyistFirstName>
          <lobbyistLastName>Holcombe</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tracey </lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Amy </lobbyistFirstName>
          <lobbyistLastName>Walker</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Kelly </lobbyistFirstName>
          <lobbyistLastName>Cappio</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Phyllis </lobbyistFirstName>
          <lobbyistLastName>Arthur</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jamie </lobbyistFirstName>
          <lobbyistLastName>Gregorian</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Erin </lobbyistFirstName>
          <lobbyistLastName>Estey Hertzog</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tracey</lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Sarah </lobbyistFirstName>
          <lobbyistLastName>Kyle</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Cartier</lobbyistFirstName>
          <lobbyistLastName>Esham</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Charles </lobbyistFirstName>
          <lobbyistLastName>Fritts</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Shelly </lobbyistFirstName>
          <lobbyistLastName>Mui-Lipnik</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>HOM</issueAreaCode>
      <specific_issues>
        <description>Biodefense Research, Development and Procurement Issues (Nonfunding) 
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Kelly </lobbyistFirstName>
          <lobbyistLastName>Cappio</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Phyllis </lobbyistFirstName>
          <lobbyistLastName>Arthur</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Nicolas</lobbyistFirstName>
          <lobbyistLastName>Magallanes</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tracey </lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Amy </lobbyistFirstName>
          <lobbyistLastName>Walker</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>MED</issueAreaCode>
      <specific_issues>
        <description>Funding for National Institutes of Health
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Biodefense Research, Development and Procurement Issues 
Senate Innovation for Healthier Americans
--Longitudinal Study of Chronic Diseases
Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017

Gene Editing Technologies
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Precision Medicine Initiative
Combating Antibiotic-Resistant Bacteria (CARB) Initiative
</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Tracey </lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Nicolas</lobbyistFirstName>
          <lobbyistLastName>Magallanes</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Amy </lobbyistFirstName>
          <lobbyistLastName>Walker</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Kelly </lobbyistFirstName>
          <lobbyistLastName>Cappio</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Phyllis </lobbyistFirstName>
          <lobbyistLastName>Arthur</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Sarah </lobbyistFirstName>
          <lobbyistLastName>Kyle</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Kathleen</lobbyistFirstName>
          <lobbyistLastName>Holcombe</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Kathleen </lobbyistFirstName>
          <lobbyistLastName> Holcombe</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Scott </lobbyistFirstName>
          <lobbyistLastName>McGoohan</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Cartier </lobbyistFirstName>
          <lobbyistLastName>Esham</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>MMM</issueAreaCode>
      <specific_issues>
        <description>Medicaid Pricing and Rebates
--Average Manufacturer Price Calculations
--Implementation of Affordable Care Act
Reimbursement for Innovative Products
--Medicare Part B Physician-Administered Products
--Medicare Part D Prescription Drug Program: 
----CMS Proposed Rule on Protected Classes
--Value-based Contracting and Communications
Government Price Reporting
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
Senate Innovation for Healthier Americans
--Patient Access to Approved Drugs
 
</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Deborah </lobbyistFirstName>
          <lobbyistLastName>Shelton</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Erin </lobbyistFirstName>
          <lobbyistLastName>Estey Hertzog</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Nicolas</lobbyistFirstName>
          <lobbyistLastName>Magallanes</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Sarah </lobbyistFirstName>
          <lobbyistLastName>Kyle</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Laurel </lobbyistFirstName>
          <lobbyistLastName>Todd</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jamie </lobbyistFirstName>
          <lobbyistLastName>Gregorian</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tracey</lobbyistFirstName>
          <lobbyistLastName> LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Kathleen </lobbyistFirstName>
          <lobbyistLastName>Holcombe</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>SMB</issueAreaCode>
      <specific_issues>
        <description>Sarbanes Oxley Section 404 (b)
--PCAOB Audit Cost Increases
--H.R. 4139: Fostering Innovation Act
XBRL Exemption for Small Public Companies
--H.R. 1965: Small Company Disclosure Simplification Act
--H.R. 1675: Capital Markets Improvement Act
Capital Market Enhancements
--H.R. 1675: Encouraging Employee Ownership Act
--H.R. 4168: Small Business Capital Formation Enhancement Act
--H.R. 3784: Securities &amp; Exchange Commission Small Business Advocate Act
--H.R. 1675: Capital Markets Improvement Act
--H.R. 2354: Streamlining Excessive and Costly Regulations Review Act
--H.R. 4638: Main Street Growth Act
Proxy Advisory Services
--Impact of Policies on Small Public Companies
--Proxy Advisory Firm Reform Act (Discussion Draft)
Reform of SEC Regulation D
--S. 978/H.R. 4498: HALOS Act
Short Selling Transparency
Capital Formation Investment Incentives
--H.R. 2179: PARTNER Act
--Reform of Capital Gains Rules
--Reform of Net Operating Loss Rules
--Reform of Passive Loss Rules
--S. 341: Start-up Jobs and Innovation Act
--S. 537: COMPETE Act
</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Charles </lobbyistFirstName>
          <lobbyistLastName>Crain</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Charles </lobbyistFirstName>
          <lobbyistLastName>Fritts</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Shelly </lobbyistFirstName>
          <lobbyistLastName>Mui-Lipnik</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Cartier</lobbyistFirstName>
          <lobbyistLastName>Esham</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>TAX</issueAreaCode>
      <specific_issues>
        <description>Biofuels (Non-Funding) 
--Production Tax Credit Extension
--S. 2658: Federal Aviation Administration Reauthorization Act of 2016
----Franken-Grassley Amendment 
Research &amp; Development Tax Credit Reforms
--Extension
--Permanency
--Refundable R&amp;D Credit
Capital Formation Investment Incentives
--H.R. 2179: PARTNER Act
--Reform of Capital Gains Rules
--Reform of Net Operating Loss Rules
--Reform of Passive Loss Rules
--S. 341: Start-up Jobs and Innovation Act
--S. 537: COMPETE Act
Tax Reform
--Innovation Box / Patent Box
Orphan Drug Act Tax Credit
Antibiotic &amp; Diagnostic Tax Credit
--H.R. 3539: Antibiotic &amp; Diagnostic Innovation Act
Inversions
--Financial Services and General Government Appropriations Act for FY 2017
Renewable Chemicals/Bio-based Products (Non-Funding)
--Investment Tax Credit for Renewable Chemicals and Bio-based Products
--S. 2271: The Renewable Chemicals Act
--S. 1656/H.R. 2883: Master Limited Partnership Parity Act
--H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act
 
</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Treasury - Dept of, Internal Revenue Service (IRS)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Charles </lobbyistFirstName>
          <lobbyistLastName>Fritts</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Shelly </lobbyistFirstName>
          <lobbyistLastName>Mui-Lipnik</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Charles </lobbyistFirstName>
          <lobbyistLastName>Crain</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tracey </lobbyistFirstName>
          <lobbyistLastName>LaTurner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Rina </lobbyistFirstName>
          <lobbyistLastName>Singh</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Cartier</lobbyistFirstName>
          <lobbyistLastName>Esham</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>TRD</issueAreaCode>
      <specific_issues>
        <description>TransPacific Partnership
--Data and Intellectual Property Protection for Pharmaceuticals
--Reimbursement Transparency 
Foreign Agricultural Biotechnology Laws and Regulations
--Asynchrony of International Approvals
--China Biotechnology Regulations
--EU Ag-Biotech Policies and Regulations
--Korea Biotechnology Regulations
--Like-minded Countries Initiatives
Biosimilars
--Brazil Biologics Regulations
Drug Importation
--Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017
--Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Pacific Alliance IP Harmonization
Transatlantic Trade and Investment Partnership
--Ag-Biotech Issues 
UN Commission on Access to Medicines </description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), Commerce - Dept of (DOC)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Joseph</lobbyistFirstName>
          <lobbyistLastName>Damond</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jamie </lobbyistFirstName>
          <lobbyistLastName>Gregorian</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Charles</lobbyistFirstName>
          <lobbyistLastName> Fritts</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Matthew </lobbyistFirstName>
          <lobbyistLastName>OMara</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Dana </lobbyistFirstName>
          <lobbyistLastName>OBrien</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Nicolas</lobbyistFirstName>
          <lobbyistLastName>Magallanes</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Jeanne</lobbyistFirstName>
          <lobbyistLastName>Haggerty</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Tom</lobbyistFirstName>
          <lobbyistLastName>DiLenge</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
  </alis>
  <updates>
    <clientAddress>
    </clientAddress>
    <clientCity>
    </clientCity>
    <clientState>
    </clientState>
    <clientZip>
    </clientZip>
    <clientZipext>
    </clientZipext>
    <clientCountry>
    </clientCountry>
    <prinClientCity>
    </prinClientCity>
    <prinClientState>
    </prinClientState>
    <prinClientZip>
    </prinClientZip>
    <prinClientZipext>
    </prinClientZipext>
    <prinClientCountry>
    </prinClientCountry>
    <generalDescription>
    </generalDescription>
    <inactive_lobbyists>
      <inactive_lobbyist>
        <firstName>Catharine </firstName>
        <lastName>Harris</lastName>
        <suffix>
        </suffix>
      </inactive_lobbyist>
      <inactive_lobbyist>
        <firstName>
        </firstName>
        <lastName>
        </lastName>
        <suffix>
        </suffix>
      </inactive_lobbyist>
      <inactive_lobbyist>
        <firstName>
        </firstName>
        <lastName>
        </lastName>
        <suffix>
        </suffix>
      </inactive_lobbyist>
      <inactive_lobbyist>
        <firstName>
        </firstName>
        <lastName>
        </lastName>
        <suffix>
        </suffix>
      </inactive_lobbyist>
    </inactive_lobbyists>
    <inactive_ALIs>
      <ali_Code>SCI</ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
    </inactive_ALIs>
    <affiliatedUrl>
    </affiliatedUrl>
    <affiliatedOrgs>
      <affiliatedOrg>
        <affiliatedOrgName>
        </affiliatedOrgName>
        <affiliatedOrgAddress>
        </affiliatedOrgAddress>
        <affiliatedOrgCity>
        </affiliatedOrgCity>
        <affiliatedOrgState>
        </affiliatedOrgState>
        <affiliatedOrgZip>
        </affiliatedOrgZip>
        <affiliatedOrgCountry>
        </affiliatedOrgCountry>
        <affiliatedPrinOrgCity>
        </affiliatedPrinOrgCity>
        <affiliatedPrinOrgState>
        </affiliatedPrinOrgState>
        <affiliatedPrinOrgCountry>
        </affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
        <affiliatedOrgName>
        </affiliatedOrgName>
        <affiliatedOrgAddress>
        </affiliatedOrgAddress>
        <affiliatedOrgCity>
        </affiliatedOrgCity>
        <affiliatedOrgState>
        </affiliatedOrgState>
        <affiliatedOrgZip>
        </affiliatedOrgZip>
        <affiliatedOrgCountry>
        </affiliatedOrgCountry>
        <affiliatedPrinOrgCity>
        </affiliatedPrinOrgCity>
        <affiliatedPrinOrgState>
        </affiliatedPrinOrgState>
        <affiliatedPrinOrgCountry>
        </affiliatedPrinOrgCountry>
      </affiliatedOrg>
    </affiliatedOrgs>
    <inactiveOrgs>
      <inactiveOrgName>
      </inactiveOrgName>
      <inactiveOrgName>
      </inactiveOrgName>
      <inactiveOrgName>
      </inactiveOrgName>
    </inactiveOrgs>
    <foreignEntities>
      <foreignEntity>
        <name>
        </name>
        <address>
        </address>
        <city>
        </city>
        <state>
        </state>
        <country>
        </country>
        <prinCity>
        </prinCity>
        <prinState>
        </prinState>
        <prinCountry>
        </prinCountry>
        <contribution>
        </contribution>
        <ownership_Percentage>
        </ownership_Percentage>
      </foreignEntity>
    </foreignEntities>
    <inactive_ForeignEntities>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
    </inactive_ForeignEntities>
  </updates>
</LOBBYINGDISCLOSURE2>